MTCH vs TERN · P/E 13, rev $3.48B vs $6.12B cap
Match Group Inc (MTCH) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Match Group Inc (MTCH) is a internet content & information company listed on NASDAQ.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported MTCH revenue for 2024-12-31 was $3.48B. Net income was $551.3M. Revenue was up 3.4% from 2023-12-31 to 2024-12-31. MTCH currently screens at market cap $8.24B and trailing P/E 13.5.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
MTCH currently screens at market cap $8.24B and trailing P/E 13.5. TERN currently screens at market cap $6.12B.
Not investment advice. Open the MTCH and TERN stock pages for the full models.
Not investment advice.